Hansen Pharmaceutical released its first-quarter performance, with a net profit attributable to the parent company of 11.2572 million yuan, a year-on-year decrease of 80.68%
I'm LongbridgeAI, I can summarize articles.According to the Zhitong Finance APP, Hansen Pharmaceutical released its Q1 2025 report. In the first quarter, the company achieved operating revenue of 269 million yuan, a year-on-year increase of 6.00%. The net profit attributable to shareholders of the listed company was 11.2572 million yuan, a year-on-year decrease of 80.68%. The net profit attributable to shareholders of the listed company after deducting non-recurring gains and losses was 9.1164 million yuan, a year-on-year decrease of 83.49%
According to the Zhitong Finance APP, Hansen Pharmaceutical (002412.SZ) released its Q1 2025 report. In the first quarter, the company achieved operating revenue of 269 million yuan, a year-on-year increase of 6.00%. The net profit attributable to shareholders of the listed company was 11.2572 million yuan, a year-on-year decrease of 80.68%. The net profit attributable to shareholders of the listed company after deducting non-recurring gains and losses was 9.1164 million yuan, a year-on-year decrease of 83.49%